Three independent discounted-cash-flow-style models value Johnson & Johnson every trading day. 0 of 3 currently price JNJ above its market price.
| Free Cash Flow model | $233.35 |
| Excess Profit model | $175.16 |
| Residual Earnings model | $215.71 |
| Dividend Discount model | $265.78 |
| Piotroski F-Score | 3 / 9 |
| Return on invested capital | +15.6% |
| Net debt / EBITDA | 0.9× |
| Gross margin | +67.9% |
| Revenue CAGR | +5.6% |
| Cash conversion | 0.9× |
| Dividend yield | +2.1% |
| Buyback yield | -0.0% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open JNJ in StockKitty